Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection

Infection and Immunity

Volumn 83, Issue 4, 2015, Pages 1443-1450

  Brumbaugh, Ariel R ^a   Smith, Sara N ^a   Subashchandrabose, Sargurunathan ^a   Himpsl, Stephanie D ^a   Hazen, Tracy H ^b   Rasko, David A ^b   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRULENCE FACTOR; YERSINIABACTIN; YERSINIABACTIN RECEPTOR; BACTERIAL VACCINE; CELL SURFACE RECEPTOR; ESCHERICHIA COLI PROTEIN; FYUA PROTEIN, E COLI; MONOCLONAL ANTIBODY; PHENOL DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CELL SURFACE; CONTROLLED STUDY; CYSTITIS; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYELONEPHRITIS; RNA SEQUENCE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CBA MOUSE; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; URINARY TRACT INFECTIONS;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL VACCINES; CYSTITIS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PHENOLS; PYELONEPHRITIS; RECEPTORS, CELL SURFACE; THIAZOLES; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84925356204     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02904-14     Document Type: Article

References (53)

1. Howard SJ, Hopwood S, Davies SC. 2014. Antimicrobial resistance: a global challenge. Sci Transl Med:6(236):236ed210. http://dx.doi.org/10.1126/scitranslmed.3009315.
2. Zhang L, Foxman B. 2003. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 8:e235-e244. http://dx.doi.org/10.2741/1007.
3. Jones RN. 2010. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 51(Suppl 1):S81-S87. http://dx.doi.org/10.1086/653053.
4. Miajlovic H, Smith SG. 2014. Bacterial self-defence: how Escherichia coli evades serum killing. FEMS Microbiol Lett 354:1-9. http://dx.doi.org/10.1111/1574-6968.12419.
5. World Health Organization. 2014. Antimicrobial resistance: global report on surveillance, p 256. World Health Organization, Geneva, Switzerland.
6. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. 2009. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34:407-413. http://dx.doi.org/10.1016/j.ijantimicag.2009.04.012.
7. Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A. 2014. Frequency assessment of beta-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci 19(Suppl 1):S41-S45.
8. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J, Jr, Infectious Diseases Society of America. 2008. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155-164. http://dx.doi.org/10.1086/524891.
9. Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413-451. http://dx.doi.org/10.1128/MMBR.00012-07.
10. Nairz M, Schroll A, Sonnweber T, Weiss G. 2010. The struggle for iron-metal at the host-pathogen interface. Cell Microbiol 12:1691-1702. http://dx.doi.org/10.1111/j.1462-5822.2010.01529.x.
11. Drakesmith H, Prentice AM. 2012. Hepcidin and the iron-infection axis. Science 338:768-772. http://dx.doi.org/10.1126/science.1224577.
12. Skaar EP. 2010. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6:e1000949. http://dx.doi.org/10.1371/journal.ppat.1000949.
13. Garcia EC, Brumbaugh AR, Mobley HL. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79:1225-1235. http://dx.doi.org/10.1128/IAI.01222-10.
14. Berger H, Hacker J, Juarez A, Hughes C, Goebel W. 1982. Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol 152:1241-1247.
15. Spurbeck RR, Dinh PC, Jr, Walk ST, Stapleton AE, Hooton TM, Nolan LK, Kim KS, Johnson JR, Mobley HL. 2012. Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun 80:4115-4122. http://dx.doi.org/10.1128/IAI.00752-12.
16. Schubert S, Cuenca S, Fischer D, Heesemann J. 2000. Highpathogenicity island of Yersinia pestis in enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis 182:1268-1271. http://dx.doi.org/10.1086/315831.
17. Lawlor MS, O'Connor C, Miller VL. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75:1463-1472. http://dx.doi.org/10.1128/IAI.00372-06.
18. Perry RD, Fetherston JD. 2011. Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis. Microbes Infect 13:808-817. http://dx.doi.org/10.1016/j.micinf.2011.04.008.
19. Brumbaugh AR, Smith SN, Mobley HL. 2013. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun 81:3309-3316. http://dx.doi.org/10.1128/IAI.00470-13.
20. Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, Jimenez de Anta MT, Vila J. 2005. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 191:46-50. http://dx.doi.org/10.1086/426450.
21. Orvis J, Crabtree J, Galens K, Gussman A, Inman JM, Lee E, Nampally S, Riley D, Sundaram JP, Felix V, Whitty B, Mahurkar A, Wortman J, White O, Angiuoli SV. 2010. Ergatis: a web interface and scalable software system for bioinformatics workflows. Bioinformatics 26:1488-1492. http://dx.doi.org/10.1093/bioinformatics/btq167.
22. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
23. Subashchandrabose S, Hazen TH, Rasko DA, Mobley HL. 2013. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates. Pathog Dis http://dx.doi.org/10.1111/2049-632X.12059.
24. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621-628. http://dx.doi.org/10.1038/nmeth.1226.
25. Subashchandrabose S, Hazen TH, Brumbaugh AR, Himpsl SD, Smith SN, Ernst RD, Rasko DA, Mobley HL. 2014. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc Natl Acad Sci U S A 111:18327-18332. http://dx.doi.org/10.1073/pnas.1415959112.
26. R Development Core Team. 2012. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
27. Kolde R. 2013. Pretty heatmaps. R package version 0.7.7. http://cran.r-project.org/web/packages/pheatmap/index.html.
28. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945. http://dx.doi.org/10.1093/bioinformatics/16.10.944.
29. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
30. Johnson DE, Lockatell CV, Hall-Craigs M, Mobley HL, Warren JW. 1987. Uropathogenicity in rats and mice of Providencia stuartii from longterm catheterized patients. J Urol 138:632-635.
31. Hagberg L, Engberg I, Freter R, Lam J, Olling S, Svanborg Eden C. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 40: 273-283.
32. Kearney JF, Radbruch A, Liesegang B, Rajewsky K. 1979. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 123: 1548-1550.
33. Gefter ML, Margulies DH, Scharff MD. 1977. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 3:231-236. http://dx.doi.org/10.1007/BF01551818.
34. Claflin JL, Hudak S, Maddalena A. 1981. Anti-phosphocholine hybridoma antibodies. I. Direct evidence for three distinct families of antibodies in the murine response. J Exp Med 153:352-364.
35. Fetherston JD, Bearden SW, Perry RD. 1996. YbtA, an AraC-type regulator of the Yersinia pestis pesticin/yersiniabactin receptor. Mol Microbiol 22:315-325. http://dx.doi.org/10.1046/j.1365-2958.1996.00118.x.
36. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72: 6373-6381. http://dx.doi.org/10.1128/IAI.72.11.6373-6381.2004.
37. Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S. 2007. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 75:1916-1925. http://dx.doi.org/10.1128/IAI.01269-06.
38. Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, Hinnebusch BJ, Buchanan SK. 2012. Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci U S A 109:9857-9862. http://dx.doi.org/10.1073/pnas.1203472109.
39. Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R, III. 2010. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine 29:274-282. http://dx.doi.org/10.1016/j.vaccine.2010.10.033.
40. Bachman MA, Miller VL, Weiser JN. 2009. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 5:e1000622. http://dx.doi.org/10.1371/journal.ppat.1000622.
41. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, Dozois CM, Weiser JN. 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79: 3309-3316. http://dx.doi.org/10.1128/IAI.05114-11.
42. Neilands JB. 1979. The ironic function of bacteriophage receptors. Trends Biochem Sci 4:115-118. http://dx.doi.org/10.1016/0968-0004(79)90396-7.
43. Chan CY, St John AL, Abraham SN. 2013. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38:349-359. http://dx.doi.org/10.1016/j.immuni.2012.10.019.
44. Brumbaugh AR, Mobley HL. 2012. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 11:663-676. http://dx.doi.org/10.1586/erv.12.36.
45. Bielecki P, Muthukumarasamy U, Eckweiler D, Bielecka A, Pohl S, Schanz A, Niemeyer U, Oumeraci T, von Neuhoff N, Ghigo JM, Haussler S. 2014. In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. mBio 5:e01075-14. http://dx.doi.org/10.1128/mBio.01075-14.
46. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6:e1001187. http://dx.doi.org/10.1371/journal.ppat.1001187.
47. Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB. 2014. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol 68:217-235. http://dx.doi.org/10.1146/annurev-micro-091313-103456.
48. Olesen B, Hansen DS, Nilsson F, Frimodt-Moller J, Leihof RF, Struve C, Scheutz F, Johnston B, Krogfelt KA, Johnson JR. 2013. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 51:1779-1785. http://dx.doi.org/10.1128/JCM.00346-13.
49. Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, Garcia C, Miguelanez S, Perez-Vazquez M, Garcia-Cobos S, Aracil B, Bautista V, Campos J. 2006. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359-2366. http://dx.doi.org/10.1128/JCM.00447-06.
50. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286-294. http://dx.doi.org/10.1086/653932.
51. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Bano J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111:5694-5699. http://dx.doi.org/10.1073/pnas.1322678111.
52. Rakin A, Schneider L, Podladchikova O. 2012. Hunger for iron: the alternative siderophore iron scavenging systems in highly virulent Yersinia. Front Cell Infect Microbiol 2:151. http://dx.doi.org/10.3389/fcimb.2012.00151.
53. Bobrov AG, Kirillina O, Fetherston JD, Miller MC, Burlison JA, Perry RD. 2014. The Yersinia pestis siderophore, yersiniabactin, and the Znu-ABC system both contribute to zinc acquisition and the development of lethal septicaemic plague in mice. Mol Microbiol 93:759-775. http://dx.doi.org/10.1111/mmi.12693.